NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has signed a deal to buy Lomb Scientific, a provider of lab chemicals, consumables, and instruments in Australia and New Zealand, for an undisclosed sum.
Lomb Scientific, which will be integrated into Thermo Fisher's Laboratory Products and Services and Analytical Technologies segments, had revenues in 2009 of A$34 million ($32.8 million), and it has around 100 employees. The company serves as a supplier to hospitals, universities, research, and analytical labs in Australia and New Zealand, as well as in parts of Asia and the Middle East.
Thermo Fisher CEO and President Marc Casper said that the buy is part of the company's goal to "expand in growing Asia Pacific markets.
"Through this acquisition, we would significantly strengthen our laboratory product offerings in the region, particularly chemicals used in life sciences, research, and industrial applications," he said. "Lomb Scientific would also expand our customer base, increasing our depth of capabilities in health sciences, such as pathology, and building on our presence in strong industrial markets, such as mining."
Thermo Fisher did not release financial details of the definitive agreement, which is still subject to regulatory approvals and closing conditions.